146 related articles for article (PubMed ID: 12747978)
1. Clinicopathological and immunohistochemical analysis of twenty-five head and neck osteosarcomas.
Junior AT; de Abreu Alves F; Pinto CA; Carvalho AL; Kowalski LP; Lopes MA
Oral Oncol; 2003 Jul; 39(5):521-30. PubMed ID: 12747978
[TBL] [Abstract][Full Text] [Related]
2. Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.
Lopes MA; Nikitakis NG; Ord RA; Sauk J
Oral Oncol; 2001 Oct; 37(7):566-71. PubMed ID: 11564577
[TBL] [Abstract][Full Text] [Related]
3. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma.
Ragazzini P; Gamberi G; Benassi MS; Orlando C; Sestini R; Ferrari C; Molendini L; Sollazzo MR; Merli M; Magagnoli G; Bertoni F; Bohling T; Pazzagli M; Picci P
Cancer Detect Prev; 1999; 23(2):129-36. PubMed ID: 10101594
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.
Park HR; Jung WW; Bertoni F; Bacchini P; Park JH; Kim YW; Park YK
Pathol Res Pract; 2004; 200(6):439-45. PubMed ID: 15310147
[TBL] [Abstract][Full Text] [Related]
5. MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.
Yoshida A; Ushiku T; Motoi T; Beppu Y; Fukayama M; Tsuda H; Shibata T
Am J Surg Pathol; 2012 Mar; 36(3):423-31. PubMed ID: 22301501
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of p53, MDM2, Ki-67 and PCNA in central giant cell granuloma and giant cell tumor.
de Souza PE; Paim JF; Carvalhais JN; Gomez RS
J Oral Pathol Med; 1999 Feb; 28(2):54-8. PubMed ID: 9950250
[TBL] [Abstract][Full Text] [Related]
7. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of cell cycle-related proteins Cyclin Dl, CDK4, p27, E2F-l and Ets-1 in chondrosarcoma of the jaws.
Si X; Liu Z
Oral Oncol; 2001 Jul; 37(5):431-6. PubMed ID: 11377231
[TBL] [Abstract][Full Text] [Related]
9. Expression of p53 protein, PCNA, and Ki-67 in osteosarcomas of bone.
Park HR; Park YK
J Korean Med Sci; 1995 Oct; 10(5):360-7. PubMed ID: 8750062
[TBL] [Abstract][Full Text] [Related]
10. Expression of ezrin and metastatic tumor antigen in osteosarcomas of the jaw.
Park HR; Cabrini RL; Araujo ES; Paparella ML; Brandizzi D; Park YK
Tumori; 2009; 95(1):81-6. PubMed ID: 19366061
[TBL] [Abstract][Full Text] [Related]
11. Rhabdomyosarcoma of the head and neck: a clinicopathological and immunohistochemical analysis of 29 cases.
Andrade CR; Takahama Junior A; Nishimoto IN; Kowalski LP; Lopes MA
Braz Dent J; 2010 Jan; 21(1):68-73. PubMed ID: 20464324
[TBL] [Abstract][Full Text] [Related]
12. P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression.
Kouvidou C; Stefanaki K; Dai Y; Tzardi M; Koutsoubi K; Darivianaki K; Karidi E; Rontogianni D; Zois E; Kakolyris S; Georgoulias V; Delides G; Kanavaros P
Anticancer Res; 1997; 17(4A):2615-9. PubMed ID: 9252690
[TBL] [Abstract][Full Text] [Related]
13. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas.
Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST
Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
Sittel C; Ruiz S; Volling P; Kvasnicka HM; Jungehülsing M; Eckel HE
Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
[TBL] [Abstract][Full Text] [Related]
16. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and CDK4 expression in periosteal osteosarcoma.
Righi A; Gambarotti M; Benini S; Gamberi G; Cocchi S; Picci P; Bertoni F
Hum Pathol; 2015 Apr; 46(4):549-53. PubMed ID: 25680902
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
19. Comment on: F. Sandra et al. "The role of MDM2 in the proliferative activity of ameloblastoma", oral oncology 2002;38(2): 153-57.
O'Neill lD
Oral Oncol; 2002 Dec; 38(8):806. PubMed ID: 12570062
[No Abstract] [Full Text] [Related]
20. Prognostic factors in the so-called malignant mesenchymoma: a clinicopathological and immunohistochemical analysis.
Adachi T; Oda Y; Sakamoto A; Terashi T; Tamiya S; Hachitanda Y; Tsuneyoshi M
Oncol Rep; 2003; 10(4):803-11. PubMed ID: 12792727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
